Literature DB >> 21855529

Model membrane studies for characterization of different antibiotic activities of lipopeptides from Pseudomonas.

Katrin Reder-Christ1, Yvonne Schmidt, Marius Dörr, Hans-Georg Sahl, Michaele Josten, Jos M Raaijmakers, Harald Gross, Gerd Bendas.   

Abstract

Lipopeptides (LPs) are a structurally diverse class of amphipathic natural products that were in the past mainly known for their surfactant properties. However, the recent discovery of their antimicrobial and cytotoxic bioactivities have fueled and renewed the interest in this compound class. Propelled by the antimicrobial potential of this compound class, in this study a range of six underinvestigated LPs from Pseudomonads were examined with respect to their antibiotic activities towards bacteria. The assays revealed that only the glycosylated lipodipeptide SB-253514, produced by Pseudomonas strain SH-C52, showed significant antibacterial activity. Since the bioactivity of LPs is commonly attributed to membrane interactions, we analyzed the molecular interactions between the LPs and bacteria-like lipid model membranes in more detail via complementary biophysical approaches. Application of the quartz crystal microbalance (QCM) showed that all LPs possess a high binding affinity towards the model membranes. Despite their similar membrane affinity, monolayer studies displayed different tendencies of LPs to incorporate into the membrane. The degree of membrane incorporation could be correlated with specific structural features of the investigated LPs, such as distance between the peptidic macrocycle and the fatty acid, but did not fully reflect their respective antibacterial activity. Cyclic voltammetry (CV) experiments further demonstrated that SB-253514 showed no membrane permeabilization effects at inhibitory concentrations. Collectively, these results suggests that the antibacterial activity of SB-253514 cannot be explained by an unspecific detergent-like mechanism generally proposed for amphiphilic molecules but instead appears to occur via a defined structural target.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21855529     DOI: 10.1016/j.bbamem.2011.08.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

Review 1.  Therapeutic cyclic lipopeptides mining from microbes: latest strides and hurdles.

Authors:  Seema Patel; Shadab Ahmed; J Satya Eswari
Journal:  World J Microbiol Biotechnol       Date:  2015-06-04       Impact factor: 3.312

2.  Genetic and functional characterization of cyclic lipopeptide white-line-inducing principle (WLIP) production by rice rhizosphere isolate Pseudomonas putida RW10S2.

Authors:  Hassan Rokni-Zadeh; Wen Li; Aminael Sanchez-Rodriguez; Davy Sinnaeve; Jef Rozenski; José C Martins; René De Mot
Journal:  Appl Environ Microbiol       Date:  2012-04-27       Impact factor: 4.792

3.  Effects of critical medium components on the production of antifungal lipopeptides from Bacillus amyloliquefaciens Q-426 exhibiting excellent biosurfactant properties.

Authors:  Pengchao Zhao; Chunshan Quan; Liming Jin; Lina Wang; Jianhua Wang; Shengdi Fan
Journal:  World J Microbiol Biotechnol       Date:  2013-01-18       Impact factor: 3.312

Review 4.  Cyclic Lipodepsipeptides From Pseudomonas spp. - Biological Swiss-Army Knives.

Authors:  Niels Geudens; José C Martins
Journal:  Front Microbiol       Date:  2018-08-14       Impact factor: 5.640

5.  The antimicrobial compound xantholysin defines a new group of Pseudomonas cyclic lipopeptides.

Authors:  Wen Li; Hassan Rokni-Zadeh; Matthias De Vleeschouwer; Maarten G K Ghequire; Davy Sinnaeve; Guan-Lin Xie; Jef Rozenski; Annemieke Madder; José C Martins; René De Mot
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

6.  Genome mining and metabolic profiling of the rhizosphere bacterium Pseudomonas sp. SH-C52 for antimicrobial compounds.

Authors:  Menno Van Der Voort; Harold J G Meijer; Yvonne Schmidt; Jeramie Watrous; Ester Dekkers; Rodrigo Mendes; Pieter C Dorrestein; Harald Gross; Jos M Raaijmakers
Journal:  Front Microbiol       Date:  2015-07-07       Impact factor: 5.640

7.  Characterization of Milkisin, a Novel Lipopeptide With Antimicrobial Properties Produced By Pseudomonas sp. UCMA 17988 Isolated From Bovine Raw Milk.

Authors:  Margot Schlusselhuber; Justine Godard; Muriel Sebban; Benoit Bernay; David Garon; Virginie Seguin; Hassan Oulyadi; Nathalie Desmasures
Journal:  Front Microbiol       Date:  2018-05-28       Impact factor: 5.640

8.  Synthetic Rhamnolipid Bolaforms trigger an innate immune response in Arabidopsis thaliana.

Authors:  W Patricio Luzuriaga-Loaiza; Romain Schellenberger; Yannick De Gaetano; Firmin Obounou Akong; Sandra Villaume; Jérôme Crouzet; Arnaud Haudrechy; Fabienne Baillieul; Christophe Clément; Laurence Lins; Florent Allais; Marc Ongena; Sandrine Bouquillon; Magali Deleu; Stephan Dorey
Journal:  Sci Rep       Date:  2018-06-04       Impact factor: 4.379

9.  Sugar-based bactericides targeting phosphatidylethanolamine-enriched membranes.

Authors:  Catarina Dias; João P Pais; Rafael Nunes; Maria-Teresa Blázquez-Sánchez; Joaquim T Marquês; Andreia F Almeida; Patrícia Serra; Nuno M Xavier; Diogo Vila-Viçosa; Miguel Machuqueiro; Ana S Viana; Alice Martins; Maria S Santos; Ana Pelerito; Ricardo Dias; Rogério Tenreiro; Maria C Oliveira; Marialessandra Contino; Nicola A Colabufo; Rodrigo F M de Almeida; Amélia P Rauter
Journal:  Nat Commun       Date:  2018-11-19       Impact factor: 14.919

Review 10.  Pseudomonas Lipopeptide-Mediated Biocontrol: Chemotaxonomy and Biological Activity.

Authors:  Feyisara Eyiwumi Oni; Qassim Esmaeel; Joseph Tobias Onyeka; Rasheed Adeleke; Cedric Jacquard; Christophe Clement; Harald Gross; Essaid Ait Barka; Monica Höfte
Journal:  Molecules       Date:  2022-01-07       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.